Aspirin alleviates cisplatin-induced acute kidney injury through the AMPK-PGC-1α signaling pathway
Authors:
- 11 May 2023
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 380, 110536
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cisplatin nephrotoxicity: a review of the literatureJournal Of Nephrology, 2017
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosisToxicology Letters, 2014
- Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluationOncology Reports, 2013
- Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative actionEuropean Journal of Pharmacology, 2007
- Signaling of Mitochondrial Biogenesis following Oxidant InjuryJournal of Biological Chemistry, 2007
- Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic RegulatorEndocrine Reviews, 2003
- Antipyretics: mechanisms of action and clinical use in fever suppressionThe American Journal of Medicine, 2001
- Sequence and organization of the human mitochondrial genomeNature, 1981
- Urinary enzymes and kidney damage by aspirin and phenacetinChemico-Biological Interactions, 1975